NDC00173-0415-00: CEFTAZIDIME FOR INJECTION.
The CEFTAZIDIME FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, special_features: WITH HANGING DEVICE FOR INTRAVENOUS ADMINISTRATION, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-337-0318, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| special_features | WITH HANGING DEVICE FOR INTRAVENOUS ADMINISTRATION |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| NSN | 6505-01-337-0318 |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | WITH HANGING DEVICE FOR INTRAVENOUS ADMINISTRATION |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |